GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 83 filers reported holding GOSSAMER BIO INC in Q3 2019. The put-call ratio across all filers is 0.65 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $531,677 | +12386.5% | 638,421 | +17893.8% | 0.00% | – |
| Q2 2023 | $4,258 | -47.4% | 3,548 | -44.8% | 0.00% | – |
| Q1 2023 | $8,096 | -93.4% | 6,426 | -88.6% | 0.00% | – |
| Q4 2022 | $122,329 | -99.2% | 56,373 | -95.6% | 0.00% | -100.0% |
| Q3 2022 | $15,414,000 | +93.6% | 1,286,706 | +35.3% | 0.00% | +100.0% |
| Q2 2022 | $7,960,000 | -3.6% | 951,006 | -0.0% | 0.00% | 0.0% |
| Q1 2022 | $8,257,000 | -18.4% | 951,268 | +6.3% | 0.00% | 0.0% |
| Q4 2021 | $10,117,000 | -10.0% | 894,500 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $11,244,000 | +4964.9% | 894,500 | +3624.9% | 0.00% | – |
| Q1 2021 | $222,000 | -4.3% | 24,014 | 0.0% | 0.00% | – |
| Q4 2020 | $232,000 | -38.0% | 24,014 | -20.3% | 0.00% | – |
| Q3 2020 | $374,000 | -74.9% | 30,114 | -73.7% | 0.00% | – |
| Q2 2020 | $1,491,000 | -4.0% | 114,714 | -25.0% | 0.00% | – |
| Q1 2020 | $1,553,000 | -35.1% | 153,014 | 0.0% | 0.00% | – |
| Q4 2019 | $2,392,000 | -86.4% | 153,014 | -85.3% | 0.00% | -100.0% |
| Q3 2019 | $17,530,000 | -24.3% | 1,044,083 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $23,158,000 | -12.9% | 1,044,083 | -14.9% | 0.00% | 0.0% |
| Q1 2019 | $26,576,000 | – | 1,226,373 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Octagon Capital Advisors LP | 1,513,138 | $19,020,000 | 4.68% |
| Omega Fund Management, LLC | 3,320,608 | $41,740,000 | 4.68% |
| Ally Bridge Group (NY) LLC | 1,175,000 | $14,770,000 | 4.34% |
| Parkman Healthcare Partners LLC | 786,870 | $9,891,000 | 2.50% |
| Palo Alto Investors LP | 1,772,950 | $22,286,000 | 1.34% |
| HHLR ADVISORS, LTD. | 7,420,974 | $93,282,000 | 1.22% |
| Ikarian Capital, LLC | 1,351,933 | $16,995,000 | 1.20% |
| Boxer Capital, LLC | 2,462,358 | $30,952,000 | 1.08% |
| ACUTA CAPITAL PARTNERS, LLC | 215,000 | $2,703,000 | 0.95% |
| EMERALD ADVISERS, LLC | 1,516,003 | $19,056,000 | 0.69% |